Lorenzo Di Cataldo

At Novaterra, we classify breakthrough technology as innovations that solve fundamental problems or open new possibilities. These technologies offer transformative solutions to significant issues or have the potential to redefine industries. The largest companies of our time will create breakthrough technologies that solve systemic problems profitably and at scale. We define these companies as Impactful, as they deliver impact at scale. Investing, for us, is more than a financial tool; its about nurturing ideas that bring significant positive change. Our commitment is to lead in identifying and nurturing the innovations that will define the future. We focus on two areas where trillion-dollar opportunities driving significant impact could emerge in the next ten years. Planet Health Decarbonisation and climate-change mitigation are crucial to preserving our planet. We envision a future where industries are fully electrified, energy is renewable, the food system is self-sustainable, and agriculture is resilient. Human Preservation We believe in a world where every human has the highest probability of survival and well-being. We invest in advancements that lead to healthier lives, from drug discovery to technologies revolutionising patient care, from alternative living forms to new cures. Our mission is to redefine venture capital by returning to its roots—backing ventures that offer genuine technological innovation and transformative impact. At Novaterra, we aim to generate attractive returns while significantly contributing to societal well-being, ensuring that progress, sustainability, and human advancement are at the forefront of our investment strategy.

We are Out Of. Were building a piece of the future through products that defy the pardigms others stop at. Tech-savy, detail-lovers, passionate about research facts and data, we rely on our in-house R&D lab, because innovation is at our core. We try, and test, and design and redesign, and sometimes we actually fail. We arent afraid of saying it, because true progress is achieved through failure. We are frank. Transparent. We let our products speak for us. And were always pushing forward, because science loves performance. #sciencelovesperformance

Prometheus è una start-up biotech fondata nel 2017 e attiva nello sviluppo di dispositivi medicali per la medicina rigenerativa, sia in ambito umano che veterinario. Il primo prodotto, Ematik, è un patch personalizzato per la cura delle ferite cutanee, pensato per accelerare la guarigione e migliorare la qualità rigenerativa dei tessuti. Con il sistema automatizzato Ematik Lab, Prometheus ha reso il trattamento riproducibile, sicuro e standardizzato, offrendo risultati affidabili sia per i professionisti medici sia per i veterinari. Nel 2025, con l’acquisizione di Alnitec, leader nel campo dell’ozonoterapia, il gruppo ha ampliato le sue competenze terapeutiche, diventando un riferimento europeo nella tecnologia rigenerativa. #Innovation #Biotech #Startup #Healthcare #MedTech #Vet #MadeInItaly

Most companies don’t lack knowledge; they lack access to it. Policies, SOPs, and docs exist, but they’re scattered, hard to find, and rarely used when needed. Ekory is a Knowledge Intelligence Platform that turns company knowledge into instant answers, clear guidance, and auto-updated training. Upload your documents: Our AI unifies them, maps connections, and makes everything searchable and actionable in seconds. With Ekory, people stop searching and start doing. They get the right answer, from the right source, at the right moment, without breaking their workflow. Knowledge, learning, and AI finally work together. Your company becomes faster, clearer, and more competent.

Emotion Network is an Italian edtech & media company, founded on the belief that stories matter when lived, and telling them well is our mission. The unique value proposition is to be at the convergence of the audiovisual production, events and education tech EU industries, favouring synergies for the talent management, creative development, production and commercial levels. Created by a group of international partners, the company has the vision to connect people and use stories to inspire, educate and entertain, to Unlock Human Potential.

At Novaterra, we classify breakthrough technology as innovations that solve fundamental problems or open new possibilities. These technologies offer transformative solutions to significant issues or have the potential to redefine industries. The largest companies of our time will create breakthrough technologies that solve systemic problems profitably and at scale. We define these companies as Impactful, as they deliver impact at scale. Investing, for us, is more than a financial tool; its about nurturing ideas that bring significant positive change. Our commitment is to lead in identifying and nurturing the innovations that will define the future. We focus on two areas where trillion-dollar opportunities driving significant impact could emerge in the next ten years. Planet Health Decarbonisation and climate-change mitigation are crucial to preserving our planet. We envision a future where industries are fully electrified, energy is renewable, the food system is self-sustainable, and agriculture is resilient. Human Preservation We believe in a world where every human has the highest probability of survival and well-being. We invest in advancements that lead to healthier lives, from drug discovery to technologies revolutionising patient care, from alternative living forms to new cures. Our mission is to redefine venture capital by returning to its roots—backing ventures that offer genuine technological innovation and transformative impact. At Novaterra, we aim to generate attractive returns while significantly contributing to societal well-being, ensuring that progress, sustainability, and human advancement are at the forefront of our investment strategy.

We are Out Of. Were building a piece of the future through products that defy the pardigms others stop at. Tech-savy, detail-lovers, passionate about research facts and data, we rely on our in-house R&D lab, because innovation is at our core. We try, and test, and design and redesign, and sometimes we actually fail. We arent afraid of saying it, because true progress is achieved through failure. We are frank. Transparent. We let our products speak for us. And were always pushing forward, because science loves performance. #sciencelovesperformance

Life is too short to breathe unsafe air. But a radical shift in business models will take too long. The planet needs action now. So, what can be done quickly to decontaminate the planet? This is what U-Earth tries to answer EVERY day. Our vision is to make pure air a human right for all. To do that, we provide cutting-edge and nature-based solutions – air purification services and hyper health products – using biotechnology that aims to empower companies and peoples transformation for the good of the Earth. The Pure Air Zone project is a new air quality standard that gives companies the opportunity to provide a pure air environment for their people. By doing this, they can take the lead in driving sustainable change and engage a community of pure air advocates throughout the Pure Air Zone App – a community mobile app that features each Pure Air Zone and lets its users vote for the air they want to breathe. U-Earth currently has offices in London, Milan, and Bucarest, with an office in the US coming soon. We work with companies across all industries focusing on sports, healthcare, services, retail, hospitality, education, and industrial environments. Customers include Microsoft, F1 teams, MotoGP, and Michelin star restaurants. Vote for clean air today: https://www.u-earth.eu/pure-air-zone-app